SLC5A2 and heart failure: Despite our previous published work and clinical studies linking SGLT2 in the pathogenesis of cardiac dysfunction and heart failure, the underlying mechanism by which SGLT2 inhibition improves cardiac function in the aged myocardium remains poorly understood.